期刊文献+

血液透析机实际透析液总流量的测定 被引量:3

Determination of total actual dialysate flow for hemodialysis machines
下载PDF
导出
摘要 目的探讨血液透析机的实际透析液流量与设定流量是否存在差异。方法清华大学第一附属医院肾脏科血液透析机共37台,3种不同品牌分为A、B、C组。选择常规血液透析时间4h病情稳定的维持性血液透析患者。通过透析废液收集器装置收集血液透析模式开始至4h结束的全部透析废液量。实际透析液总流量=全部透析废液量-超滤总量。比较实际流量与设定值(120L)的差异。结果全部机器实际总透析液流量平均(117.784±5.970)L,小于120L者25台占67.4%,大于120L者共12台占32.4%。A组18台机器平均透析液总流量[120.333±6.598(110-133)]L,B组13台机器平均透析液总流量[116.131±3.938(111-123)]L,C组6台机器平均透析液总流量[113.717±4.598(105-117)]L。单因素方差分析3组间存在明显统计学差异(F=4.150,P=0.024)。C组调试后实际透析液总流量为[120.075±0.529(119.4-121)]L。结论血液透析机实际透析液总流量普遍存在偏离,其中以负偏离居多。不同厂家透析机实际透析液总流量存在差异,通过调试可以达到设定目标。 Objective To investigate whether there is a difference between actual dialysate flow and set dialysate flow ofhemodialysis machines. Methods There are 37 hemodialysis machines in our center. We divided the three brands of machines into A, B and C groups. We selected stable patients on conventional hemodialysis. Total waste dialysate during a 4-hour hemodialysis session was collected. The actual total dialysate flow is equal to the total waste dialysate minus the total ultrafiltration volume. We compared the difference between the actual total dialysate flow and the set dialysis flow (120L). Result The actual total dialysate flow was 117.78±5.97L for all machines, less than 120L in 25 hemodialysis machines (67.6%) and more than 120L in 12 machines (32.4%). There was a significant difference between the 3 groups (ANOVA, F=4.150, P= 0.024). After debugging, the total dialysate flow in Group C improved significantly [120.075±0.529L (119.4- 121.0L) vs. 113.717±4.588 L(105-117L)]. Conclusion Deviation of actual total dialysate flow existed among hemodialysis machines, and most of them had negative deviation. There were differences in the actual total dialysate flow among machines of different manufactures, and the set dialysate flow can be achieved after debugging
出处 《中国血液净化》 2016年第8期441-443,共3页 Chinese Journal of Blood Purification
关键词 透析液总流量 维持性血液透析 Total dialysate flow Hemodialysis
  • 相关文献

参考文献6

  • 1Ledebo I. Purification of dialysis fluid: historical background and perspective [J]. Blood purif, 2009, 27 (Suppl 1):17-19.
  • 2Hoenich NA, Levin R, Ronco C. How do changes in water quality and dialysate composition affect clinical out- comes[J]? Blood purif, 2009, 27(1):11-15.
  • 3那宇,柳慧敏.高通量透析的研究进展[J].中华肾病研究电子杂志,2015,4(3):10-13. 被引量:12
  • 4Kashiwagi T, Sato K, Kawakami S, et al. Effects of re- duced dialysis fluid flow in hemodialysis[J]. J Nip- pon Med Sch, 2013, 80(2):119-130.
  • 5Albalate M, Perez-Garcia R, de Sequera P, et al. Is it useful to increase dialysate flow rate to improve the delivered Kt[J] BMC nephrology, 2015, 16(2):20.
  • 6卢方平.尿毒症中分子毒素与血液灌流[J].国际移植与血液净化杂志,2006,4(1):8-11. 被引量:40

二级参考文献33

  • 1吴平勇,张庆红,张建鄂,李涛,张永,王顺华,李新华.高通量透析可改善维持性血液透析患者肾性贫血[J].生物医学工程与临床,2005,9(1):40-44. 被引量:9
  • 2许传文.高通量透析对血β_2微球蛋白浓度及蛋白质浓度的影响[J].临床内科杂志,2005,22(6):424-425. 被引量:1
  • 3Eknoyan G, Beck G J, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis [ J ]. N Engl J Med, 2002, 347 (25) : 2010-2019.
  • 4Malyszko JS, Malyszko J, Hryszko T, et al. Markers of endothelial damage in patients on hemodialysis and hemodiafiltration [ J ]. J Nephrol, 2006, 19(2): 150-154.
  • 5Raggi P, Vukicevic S, Moyses RM, et al. Ten-year experience with sevelamer and calcium salts as phosphate binders [ J ]. Clin J Am Soc Nephrol, 2010, 5 (Suppl 1 ) : $31-$40.
  • 6Penne EL, van der Weerd NC, Grooteman MP, et al. Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients [ J ]. Clin J Am Soe Nephrol, 2011, 6(2) : 281-289.
  • 7Kong X, Zhang L, Zhang L, et al. Mineral and bone disorder in Chinese dialysis patients: a muhicenter study [ J ]. BMC Nephrology, 2012, 13 : 116.
  • 8Floege J, Kim J, Ireland E, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population [ J ]. Nephrol Dial Transplant, 2011, 26 ( 6 ) : 1948- 1955.
  • 9Shidara K, Inaba M, Okuno S, et al. Influence of nutritional status on serum large N-truncated PTH, but not PTH (1-84) in hemodialysis patients [ ]]. Biomed Pharmacother, 2007,61 (2/3) : 142-147.
  • 10Lugon JR, Andre ME, Duarte ME, et al. Effects of incenter daily hemodialysis upon mineral metabolism and bone disease in end-stage renal disease patients [J]. Sao Paulo Med J, 2001, 119(3) : 105- 109.

共引文献50

同被引文献12

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部